These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 3639555

  • 1. [Clinical observation of a case of nephrotic syndrome].
    Aubert P, Weil G.
    Soins; 1986 May; (477-478):43-4. PubMed ID: 3639555
    [No Abstract] [Full Text] [Related]

  • 2. Does albumin and furosemide therapy affect plasma volume in nephrotic children?
    Bircan Z, Kervancioğlu M, Katar S, Vitrinel A.
    Pediatr Nephrol; 2001 Jun; 16(6):497-9. PubMed ID: 11420914
    [Abstract] [Full Text] [Related]

  • 3. Treatment of nephrotic edema with bumetanide.
    Lemieux G, Beauchemin M, Gougoux A, Vinay P.
    Can Med Assoc J; 1981 Nov 15; 125(10):1111-2, 1117. PubMed ID: 7034916
    [Abstract] [Full Text] [Related]

  • 4. [The role of hypervolemia in the pathogenesis of hypoalbuminemia in the nephrotic syndrome].
    Klepikov PV.
    Ter Arkh; 1991 Nov 15; 63(6):16-9. PubMed ID: 1948734
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of severe nephrotic edema with albumin and furosemide.
    Weiss RA, Schoeneman M, Greifer I.
    N Y State J Med; 1984 Aug 15; 84(8):384-6. PubMed ID: 6592472
    [No Abstract] [Full Text] [Related]

  • 6. Pathogenesis of edema formation in the nephrotic syndrome.
    Donckerwolcke RA, Vande Walle JG.
    Kidney Int Suppl; 1997 Mar 15; 58():S72-4. PubMed ID: 9067949
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical application of albumin: a closer look at indications].
    Smorenburg CH, ter Wee PM, Gans RO.
    Ned Tijdschr Geneeskd; 1997 Apr 12; 141(15):719-23. PubMed ID: 9213788
    [Abstract] [Full Text] [Related]

  • 8. Clinical pharmacokinetics of furosemide in children with nephrotic syndrome.
    González-Martín G, Bravo I, Ibarra N, Arancibia A.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec 12; 21(12):598-601. PubMed ID: 6668097
    [Abstract] [Full Text] [Related]

  • 9. [Molecular mechanism of edema formation in nephrotic syndrome].
    Deschênes G, Guigonis V, Doucet A.
    Arch Pediatr; 2004 Sep 12; 11(9):1084-94. PubMed ID: 15351000
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of dietary protein augmentation associated with angiotensin-converting enzyme inhibition in the management of the nephrotic syndrome.
    Garini G, Mazzi A, Allegri L, Buzio C, Borghetti A.
    Miner Electrolyte Metab; 1996 Sep 12; 22(1-3):123-7. PubMed ID: 8676802
    [Abstract] [Full Text] [Related]

  • 11. [Factors participating in the mechanism of nephrotic edema and statistical assessment of their pathogenetic role with the aid of analysis of variance of some clinical data].
    Ratner MIa, Tomilina NA.
    Patol Fiziol Eksp Ter; 1968 Sep 12; 12(1):72-8. PubMed ID: 5742900
    [No Abstract] [Full Text] [Related]

  • 12. Cranial edema associated with a protein-losing nephropathy in a golden-mantled flying fox (Pteropus pumilus).
    Deem SL, Heard DJ, Clippinger TL, Buergelt CD.
    J Zoo Wildl Med; 1999 Mar 12; 30(1):126-31. PubMed ID: 10367654
    [Abstract] [Full Text] [Related]

  • 13. Plasma volume and effect of high dose frusemide in nephrotic syndrome.
    Wadehra DN, Kumar R, Gopinath PG.
    J Assoc Physicians India; 1979 Oct 12; 27(10):955-8. PubMed ID: 541316
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of the nephrotic syndrome with concentrated human albumin.
    WILLIAMS RS, RYAN TJ.
    Lancet; 1958 Nov 08; 2(7054):988-90. PubMed ID: 13599458
    [No Abstract] [Full Text] [Related]

  • 15. Muzolimine vs. furosemide in nephrotic syndrome: further support of different carrier(s) operating for enteral absorption.
    Bazzato G, Coli U, Landini S, Fracasso A, Righetto F, Scanferla F, Forte M, Morachiello P.
    Z Kardiol; 1985 Nov 08; 74 Suppl 2():92-5. PubMed ID: 4002811
    [Abstract] [Full Text] [Related]

  • 16. Clinical spectrum and complications of the nephrotic syndrome.
    Abrass CK.
    J Investig Med; 1997 Apr 08; 45(4):143-53. PubMed ID: 9154294
    [No Abstract] [Full Text] [Related]

  • 17. [Some data on the developmental mechanism of nephrotic edema].
    Matveev MP, Chudnovskaia MV, Sukhanberdina FKh.
    Vopr Okhr Materin Det; 1969 Apr 08; 14(7):40-4. PubMed ID: 5367729
    [No Abstract] [Full Text] [Related]

  • 18. Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome.
    Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Nishimura G, Hiramoto R, Honda M.
    Nephrol Dial Transplant; 2008 Aug 08; 23(8):2531-6. PubMed ID: 18258739
    [Abstract] [Full Text] [Related]

  • 19. Encephalopathy after furosemide use in nephrotic syndrome.
    Sharma AP, Grimmer J.
    J Paediatr Child Health; 2007 Mar 08; 43(3):188-90. PubMed ID: 17316196
    [Abstract] [Full Text] [Related]

  • 20. Interstitial fluid volume, plasma volume and colloid osmotic pressure in patients with nephrotic syndrome.
    Fauchald P, Noddeland H, Norseth J.
    Scand J Clin Lab Invest; 1984 Nov 08; 44(7):661-7. PubMed ID: 6531655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.